Conservative treatment of chronic pancreatitis

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 9, 2002, Pages 943-949

  Khalid, Asif ^a   Whitcomb, David C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cholecystokinin; Digestive enzymes; Pancreas; Pancreatitis; Pseudocysts; Stelate cells

Indexed keywords

PANCREAS ENZYME;

ALCOHOL CONSUMPTION; CHRONIC PANCREATITIS; CONSERVATIVE TREATMENT; HUMAN; LIFESTYLE; PAIN ASSESSMENT; PANCREAS DUCT STENOSIS; PANCREAS FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOCYST; REVIEW; SMOKING;

CHRONIC DISEASE; ENDOCRINE SYSTEM DISEASES; EXOCRINE GLANDS; HUMANS; PAIN; PANCREATITIS;

EID: 0036733518     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200209000-00004     Document Type: Review

References (94)

1. Chronic relapsing pancreatitis: A study of 29 cases without associated disease of the biliary or gastrointestinal tract
2. The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis
3. Progression of alcoholic acute to chronic pancreatitis
4. Identification, culture, and characterization of pancreatic stellate cells in rats and humans
5. Periacinar stellate-shaped cells in rat pancreas: Identification, isolation and culture
6. Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis
7. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical - Surgical series of 245 patients
8. Chronic pancreatitis: Diagnosis, classification, and new genetic developments
9. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease
10. The course of pain is the same in alcohol- and non-alcohol-induced chronic pancreatitis
11. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
12. Prognosis of chronic pancreatitis: An international multicenter study
13. Pancreatic duct pressure in chronic pancreatitis
14. Pancreatic tissue fluid pressure in chronic pancreatitis. Relation to pain, morphology, and function
15. Pancreatic tissue and ductal pressures in chronic pancreatitis
16. Endoscopic measurement of pancreatic blood flow
17. Compartment syndrome in experimental chronic obstructive pancreatitis: Effect of decompressing the main pancreatic duct
18. Pancreatic interstitial pH in human and feline chronic pancreatitis
19. Analysis of nerves in chronic pancreatitis
20. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide
21. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin
22. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes
23. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis
24. Protease-specific suppression of pancreatic exocrine secretion
25. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis
26. Creon (enteric coated pancreatin microspheres) for the treatment of pain in chronic pancreatitis: A double-blind randomised placebo-controlled crossover study
27. Treatment of pain with pancreatic extracts in chronic pancreatitis: Results of a prospective placebo-controlled multicenter trial
28. No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis
29. Does allopurinol reduce pain of chronic pancreatitis?
30. Antioxidant therapy for recurrent pancreatitis: Placebo-controlled trial
31. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency
32. Fecal elastase test: Evaluation of a new non-invasive pancreatic function test
33. Faecal elastase 1: A novel highly sensitive and specific tubeless pancreatic function test
34. Immunoreactive elastase 1: Clinical evaluation of a new non-invasive test of pancreatic function
35. Comparison of fecal elastase-1 with other indirect pancreatic function tests
36. Fecal elastase 1 determination in chronic pancreatitis
37. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children
38. Faecal elastase 1 in children with cystic fibrosis
39. Stool elastase as a diagnostic test for pancreatic function in children with cystic fibrosis
40. Elastase and chymotrypsin B in pancreatic juice and feces
41. Studies on the sterol-binding capacity of human pancreatic elastase
42. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis
43. Fecal elastase-1: Not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency
44. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: A collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology
45. Relationship between alcoholism and pancreatic insufficiency
46. Chronic pancreatitis
47. Steatorrhoea: You cannot trust your eyes when it comes to diagnosis
48. Rapid method for the determination of fat in feces
49. Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption
50. Microscopic examination of the stool for steatorrhoea
51. Incidence and severity of nutritional deficiency states in chronic exocrine pancreatic insufficiency: Comparison with nontropical sprue
52. Vitamin B12 malabsorption in chronic pancreatic insufficiency
53. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis
54. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes
55. Colonic strictures in cystic fibrosis
56. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules
57. Impaired acid neutralization in the duodenum in pancreatic insufficiency
58. Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine
59. Pancreatic enzyme replacement: The effect of antacids or cimetidine
60. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to pancreatic insufficiency
61. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis
62. Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas
63. Effects of a proton-pump inhibitor in cystic fibrosis
64. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency
65. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region
66. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhea due to cystic fibrosis
67. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency
68. Inactivation of human lipase by proteases
69. Crystallization and preliminary X-ray study of a lipase from Pseudomonas glumae
70. Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content
71. Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: A new therapy of steatorrhea?
72. Oroileal transit of slow release 5-ASA
73. The gastrointestinal interdigestive housekeeper: Motor correlates of the interdigestive myoelectric complex of the dog
74. The gastric peristalsis of the interdigestive housekeeper
75. Der einfluß eines säuregeschützten, mikroverkapselten pankreatinpräparats auf die pankreatogene steatorrhö
76. Therapie der pankreatogenen steatorrhoea: Bietet der säureschutz für pankreasenzyme vorteile?
77. Survival of human pancreatic enzymes during small bowel transit: Effect of nutrients, bile acids, and enzymes
78. Altered post prandial motility in chronic pancreatitis: Role of malabsorption
79. Luminal availability and digestive efficacy of substituted enzymes in pancreatic insufficiency
80. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal
81. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon
82. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man
83. Human pancreatic secretion and intestinal motility: Effects of ileal nutrient perfusion
84. Modulation of periodic interdigestive gastrointestinal motor and pancreatic function by the ileum
85. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis
86. Pathology of the pancreas in diabetes mellitus
87. The enteroinsular axis
88. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution
89. Glucagon secretion in acute and chronic pancreatitis
90. Glucose counterregulation in diabetes secondary to chronic pancreatitis
91. Diabetes mellitus secondary to chronic pancreatitis
92. Diabetic retinopathy in chronic pancreatitis
93. Alcohol-induced pancreatitis (AIP)
94. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM